Index M

Macrocytic anemia 674t, 684-687

Macroglobulinemia (Waldenström's) 737-739

Macrolides 1371t

Macrophages 1353

Macula 1288

in diabetic retinopathy 1303

Macular degeneration (see Maculopathy)

Maculopathy, age-related 1304-1305

Magnesium 582-583

decrease in (hypomagnesemia) 583-584

increase in (hypermagnesemia) 584

Magnesium carbonate 535

Magnesium chloride 584

Magnesium hydroxide 584

Magnesium sulfate 584

Magnetic resonance imaging

in aortic dissection 940

in cardiovascular disorders 831-832

in dementia 363

of fractures 216

in hemorrhagic stroke 421

in ischemic stroke 408, 414

in muscular disorders 515

in subdural hematoma 423

Malabsorption 1095-1104, 1098t-1100t

fat 1088-1089, 1097

Malignancy (see Cancer and specific sites and types of malignancies)

Malingering 328

Mallet finger 536, 537f

Mallory-Weiss tears 1110

Malnutrition 595-603, 596t

in alcoholism 335

anemia with 679

depression and 311t

diagnosis of 598-601, 599f, 600t

etiology of 597-598, 597t

in hospitalized patient 98-99

in medical illness 598

nursing strategies for 602t

screening for 47t

surgical risk and 244

treatment of 601-603, 602t (see also Parenteral nutrition)

vitamin deficiencies in 588

Mammography 48t, 718t, 1212, 1219, 1220-1221, 1221t

Managed care 156-164, 157f, 162t

chronic illness management in 163-164

health risk appraisal in 158-161, 160f

long-term care and 162-163

medical director in 158

Medicare 156-158, 159t

models of 157-158

Manganese intoxication 444t

Mania 312-314

lithium for 320

Mannitol

in glaucoma 1300t

in increased intracranial pressure 422t

Manometry, anorectal

in constipation 1083

in fecal incontinence 1093-1094

Marasmus 595, 601

in hospitalized patient 99

Marijuana, sexual function and 1164t

Marjolin's ulcer 1271, 1280

Marshall-Marchetti-Krantz procedure 978

Massage 278

Mastectomy 1222, 1225

sexual activity after 1162

Mastication, disorders of 1024

Mastoid, tumors of 1340

Mattress, in pressure sore prevention 1268t-1269t

Maximum allowable workload 279, 280t

Mazindol, sexual function and 1163t

McCune-Albright syndrome 470

McGuire prosthesis 978

Mean corpuscular volume 674, 674t

Meares-Stamey test 1188

Mechlorethamine (nitrogen mustard)

in Hodgkin's disease 747t

Meckel's diverticulum 1110

Meclofenamate sodium 386t, 492t

Median nerve, compression of 540-541

Mediastinum, compression of 933, 940

Medicaid 168-169

long-term care benefit of 141

MedicAlert Foundation 1416

Medicare 164-168

drug benefit of 84, 164

home health care benefit of 88-89

hospice benefit of 91

hospital care benefit of 164

last-year-of-life expenditures of 17

managed care organizations of 156-158, 159t

skilled nursing facility benefit of 105-106

social health maintenance organizations of 171

supplemental insurance and 170

Medicare Advantage Plans 164, 164

Medicare Modernization Act 164

Medigap insurance 170

Medroxyprogesterone

in endometrial hyperplasia 1216

with estrogen replacement therapy 1212

sexual function and 1164t

Medulla, ischemia of 405-406, 407t

Megacolon

idiopathic 1082

toxic 1059, 1060

Megaesophagus 1035

Megestrol acetate

in breast cancer 1226t

in dying patient 118

for hot flashes 1216

Melancholia 312

Melanoma 1282-1284, 1283t

lentigo maligna conversion to 1278

resources on 1412

Melatonin 658

in insomnia 457

Melphalan 736

Memantine 365, 366t

Membranous nephropathy 956, 957

Memory

aging and 308, 357, 380

in Alzheimer's disease 365

assessment of 348

in dementia 358, 361t

Ménétrier's disease 1047-1048

Meniere's disease 184t, 1330t

Meningitis

clinical presentation of 39

cryptococcal 1376t, 1380

treatment of 1368t

trimethoprim-associated 1372t

tuberculous 764

Menopause 1208-1211

bone loss after 467-468, 469t, 474

estrogen replacement therapy for 1211-1217, 1213t (see also Estrogen replacement therapy)

resources on 1419

sexual function after 1158-1159, 1174-1179, 1175t

vaginal bleeding after 1193-1194, 1193t

Mental health 307-310

Mental status

in anemia 675

in delirium 351-352, 353t

deterioration of (see Delirium; Dementia)

examination of 38, 50t, 343-350

     clinical assessment in 344-349

     in dementia 360, 361t, 362t

     quantitative assessment in 344, 345t, 349-350

during hospitalization 99-100

Meperidine 390-391

adverse effects of 63t

analog of 444t

Meprobamate, adverse effects of 65t

Mercaptopurine 1064t, 1065

Meropenem 1370t

Mesalamine 1064, 1064t

in ulcerative colitis 1061t

Mesenteric arterym, occlusion of 1117, 1119

Mesenteric vein, thrombosis of 1119

Mesentery

ischemia of 1118-1119

tumors of 1152-1153

Mesoridazine, sexual function and 1164t

Metabolic acidosis 585-586, 585t

Metabolic alkalosis 586-387

Metabolic disorders (see also specific disorders)

acid-base 584-588

of bone 472-486, 474f

calcium 572-580

depression and 311t

magnesium 582-584

mineral 572-584

myoclonus in 450t

phosphate 580-582

potassium 568-571

sodium 561-568

Metabolic equivalent (MET) 279, 280t

for exercises 301t

Metabolic rate 605

Metabolic syndrome 625

Metatarsalgia 553

Metatarsophalangeal Joint Pain 553

Metaxalone, adverse effects of 64t

Metformin 73, 631, 632t, 635t

Methacycline 1373t

Methazolamide 1300t

Methicillin 1367t-1368t

Methimazole 652

Methionine, metabolic defects in 690

Methocarbamol, adverse effects of 64t

Methotrexate

in breast cancer 1226t

in bullous pemphigoid 1257

in Crohn's disease 1065

drug interactions with 68t

in psoriasis 1255

in rheumatoid arthritis 502

sexual function and 1164t

Methylcellulose, in diarrhea 1091t

N-Methyl-D-aspartate (NMDA) inhibitors 395t

Methyldopa

adverse effects of 64t

autoantibody formation with 680

parkinsonism with 444t

sexual function and 1163t, 1164t

Methylphenidate 73

in cancer pain management 722

in depression 320

for dying patient 121

Methylprednisolone 1060, 1061t

Metipranolol 1300t

Metoclopramide

aging effect on 61t

in bezoar therapy 1051

drug interactions with 68t

parkinsonism with 444t

sexual function and 1163t

Metolazone

in hypertension 839t

Metoprolol 888t

in angina 856

in hypertension 843t

sexual function and 1164t

Metric system 1386-1387

Metronidazole 1371t

in antibiotic-associated diarrhea and colitis 1067

in Crohn's disease 1064t, 1065

in diarrhea 1091t

in Helicobacter pylori infection 1047

warfarin interaction with 68t

Mexiletine 888t

in muscle cramps 535

in pain management 393, 394t

theophylline interaction with 68t

Mezlocillin 1368t

Microaneurysms 1302, 1303t

Microangiopathic hemolytic anemia 680-681, 682

Microcytic anemia 674t, 675-677

Micrographia 435

Microhematuria 989

Microwave diathermy 276

Micturition 970f (see also Urinary incontinence)

syncope with 175

Midazolam, aging effect on 61t, 62

Midodrine 848

in multiple system atrophy 442

Miglitol 633, 635t

Milk-alkali syndrome 578

Milliequivalent (mEq) 1386

Milliosmole (mOsm) 1386

Milrinone 909

Mineralocorticoids, excess of 586-587

Mineral oil 1085

Minerals

disorders of 572-584 (see also specific disorders)

in frailty prevention 48t

trace 594-595

Minimal change disease 956, 957

Mini-Mental State Examination 43t, 345t, 349

Mini Nutritional Assessment 598, 599f

Minocycline 1373t

in rosacea 1249

Minoxidil

in hypertension 843t

Misoprostol

in peptic ulcer disease 1046-1047

urinary incontinence with 967t

Mitomycin C 1226t

Mitral valve

in infective endocarditis 878

percutaneous balloon valvuloplasty for 949-950

prolapse of 875

regurgitation

     acute 873-874

     chronic 874-876

replacement of 947-949

stenosis 871-873

Mixed connective tissue disease 506, 527

Mobility

falls and 195

Moexipril

in hypertension 842t

Mohs' surgery 1280, 1284

Monoamine oxidase

age-related changes in 381, 382t

inhibitors of, sexual function and 1163t, 1164t

Monobactams 1370t

Monoclonal antibodies, in breast cancer 1227-1228, 1227t

Monoclonal gammopathy 1358-1359, 1384-1385

of undetermined significance 737

Monosodium urate crystals 494-496

Mood

disorders of (see Depression; Mania)

in mental status examination 345, 347

perimenopausal changes in 1209

Moore prosthesis 226, 227f

Morbidity

rates of 20-21

Moricizine 888t

Morphine 387t, 391

aging effect on 60t

in dying patient 117

in dyspnea 118

in myocardial infarction 859

Mortality (see also Death)

exercise and 297

US 11-14, 13t, 14f

world 14f, 20-21

Morton's neuroma 553

Motor function

driving and 232-233

evaluation of 37

oral 1024-1025

Mouth

age-related changes in 1000-1001

benign mucosal disorders of 1017-1019

cancer of 1021-1023

     screening for 718t

candidiasis of 1018-1019

disorders of 1013-1030, 1020t-1021t, 1026t

drug-induced problems of 1020t-1021t

dry 1028-1030

     drug-induced 1020t-1021t

     in Sjögren's syndrome 505, 1028

erythema multiforme of 1020t

motor disorders of 1024-1025

in physical examination 28t, 33

pigmented lesions of 1020t-1021t

taste disturbances of 1025-1027, 1026t

teeth of (see Teeth)

tongue of (see Tongue)

xerostomia of (see Mouth, dry)

Movement disorders 428-450, 430t, 431f (see also specific disorders)

in sleep 459, 460, 460

Moxalactam 1369t

Moxifloxacin 1369t

M protein 737

MRI (see Magnetic resonance imaging)

Multidisciplinary teams (see Interdisciplinary teams)

Multi-infarct dementia 367

Multiple myeloma 732-737

Multiple system atrophy 442-443

parkinsonism in 444t

Multivitamin 588

Murmur (see also Heart murmurs)

in aortic dissection 939

in thoracic aortic aneurysm 933

Muscle(s)

age-related changes in 296, 471-472

atrophy of 516t-517t

     in hyperthyroidism 529

     in inclusion body myositis 524

biopsy of 519

contraction of 471

cramps of 533-535

disorders of 511-535, 518t (see also specific disorders)

     classification of 512t

     dysphagia in 1031, 1031t, 1034, 1034t

     etiology of 514t-515t, 516t-517t

electrical stimulation of 276-277

evaluation of 36

fatigue of 511-512

immobilization-related deconditioning of 472

mass of

     loss of (see Sarcopenia)

     measurement of 519-520

sarcopenia of (see Sarcopenia)

strengthening exercises for 271, 303-304, 471

     after stroke 281

strength grading of 272t

weakness of 511, 516t-517t

     with corticosteroid therapy 527-528

     in dermatomyositis 525

     in Eaton-Lambert syndrome 522-523

     in hyperkalemia 532

     in hyperthyroidism 529

     in hypothyroidism 529

     in inclusion body myositis 524

     in male hypogonadism 1173

     in myasthenia gravis 520-521

     in osteomalacia 531

     in polymyositis 526

Muscle relaxants 395t

adverse effects of 65t

Muscular dystrophy, oculopharyngeal 533

Musculoskeletal system (see also Bone; Muscle[s])

age-related changes in 467-472, 469t

physical examination of 28t, 36

Myasthenia gravis 517t, 520-522

Myasthenic crisis 521

Mycobacterium tuberculosis infection 760, 763-767 (see also Tuberculosis)

Myelocytic (myeloid, myelogenous) leukemia

acute 724-728

chronic 728-732

     vs. primary thrombocythemia 707

Myelodysplastic syndromes 739-742

vs. chronic myeloproliferative disorders 704t

vs. primary thrombocythemia 707

Myelofibrosis 711-714, 713t

polycythemia vera transformation to 709

Myeloid disorders 703-714, 704t, 705f

Myeloma, multiple 732-737

Myeloproliferative disorders 703-714, 704t, 705f

vs. myelodysplastic syndrome 704t

Myerson's sign 435

Myocardial infarction 858-863, 862t-863t

antihypertensives in 843t

anxiety and 323t

aspirin in 702

clinical presentation of 40

electrocardiography in 825-826

fibrinolytic therapy in 700

rehabilitation after 278-279, 280t

reperfusion therapy in 860-861

sexual activity after 1159

stroke and 397

venous thromboembolism prophylaxis for 696, 927

Myocardium

age-related changes in 813, 818-819

infarction of (see Myocardial infarction)

infection of 878-885, 881t, 883t-884t

Myoclonus 430t, 448-450, 450t

nocturnal 459-460

palatal 1330t

Myoedema 530

Myokymia, in hyperthyroidism 528-529

Myopathy, hypokalemic 531-532 (see also Muscle(s), disorders of)

Myositis, inclusion body 523-524

Myotomy, in achalasia 1036

Myotonic dystrophy 532-533

Myringosclerosis, tinnitus and 1330t

Myxedema 643-647